Charles Cha

4.9k total citations
79 papers, 2.5k citations indexed

About

Charles Cha is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Charles Cha has authored 79 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 27 papers in Surgery and 25 papers in Hepatology. Recurrent topics in Charles Cha's work include Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Charles Cha is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Charles Cha collaborates with scholars based in United States, China and Hong Kong. Charles Cha's co-authors include Ronald P. DeMatteo, Leslie H. Blumgart, Yuman Fong, William R. Jarnagin, Marc Ladanyi, Ronald W. Lewis, S.C. Jhanwar, John H. Healey, Andrew G. Huvos and Peter S. Yoo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Psychologist.

In The Last Decade

Charles Cha

78 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Cha United States 24 973 707 692 600 562 79 2.5k
Graeme J. Poston United Kingdom 20 1.6k 1.6× 1.0k 1.5× 627 0.9× 637 1.1× 271 0.5× 45 2.5k
Francesco Leone Italy 26 1.4k 1.5× 364 0.5× 612 0.9× 906 1.5× 381 0.7× 134 2.5k
Gerrit DeBoer Canada 26 1.1k 1.1× 379 0.5× 965 1.4× 513 0.9× 755 1.3× 43 2.8k
Cinzia Orlandini Italy 29 2.2k 2.3× 478 0.7× 877 1.3× 748 1.2× 622 1.1× 74 3.7k
Maria Giulia Zampino Italy 23 1.7k 1.8× 272 0.4× 808 1.2× 625 1.0× 318 0.6× 95 2.5k
Jörg Trojan Germany 29 1.2k 1.2× 1.3k 1.9× 708 1.0× 699 1.2× 812 1.4× 154 3.3k
Jeffrey Meyer United States 23 621 0.6× 511 0.7× 790 1.1× 573 1.0× 249 0.4× 125 2.3k
Howard J. Lim Canada 28 1.1k 1.1× 233 0.3× 593 0.9× 383 0.6× 610 1.1× 184 2.3k
Hop S. Tran Cao United States 27 1.4k 1.5× 255 0.4× 672 1.0× 991 1.7× 433 0.8× 156 2.6k
Sanjeev A. Vasudevan United States 27 682 0.7× 232 0.3× 426 0.6× 541 0.9× 801 1.4× 118 2.2k

Countries citing papers authored by Charles Cha

Since Specialization
Citations

This map shows the geographic impact of Charles Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Cha more than expected).

Fields of papers citing papers by Charles Cha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Cha. The network helps show where Charles Cha may publish in the future.

Co-authorship network of co-authors of Charles Cha

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Cha. A scholar is included among the top collaborators of Charles Cha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Cha. Charles Cha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moaven, Omeed, Thomas E. Tavolara, Cristian D. Valenzuela, et al.. (2023). Machine Learning Models for Predicting the Outcomes of Surgical Treatment of Colorectal Liver Metastases. Journal of the American College of Surgeons. 236(4). 884–893. 3 indexed citations
2.
Solsky, Ian, Omeed Moaven, Cristian D. Valenzuela, et al.. (2023). Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease. Annals of Surgical Oncology. 30(7). 4264–4273. 2 indexed citations
4.
Klemen, Nicholas D., Melinda Wang, Jill C. Rubinstein, et al.. (2020). Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma. Journal for ImmunoTherapy of Cancer. 8(1). e000341–e000341. 63 indexed citations
5.
Kurbatov, Vadim, Benjamin J. Resio, Danielle R. Heller, et al.. (2020). Liver-first approach to stage IV colon cancer with synchronous isolated liver metastases. Journal of Gastrointestinal Oncology. 11(1). 76–83. 4 indexed citations
6.
Cha, Charles, et al.. (2019). Primary Mesothelioma of the Liver: A Case Report. 24(4). e3–e10. 1 indexed citations
7.
Uhlig, Johannes, Charles Cha, Sajid Khan, et al.. (2019). Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database. Annals of Surgical Oncology. 26(7). 1993–2000. 12 indexed citations
8.
Klemen, Nicholas D., Melinda Wang, Paul L. Feingold, et al.. (2019). Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma. Journal for ImmunoTherapy of Cancer. 7(1). 196–196. 54 indexed citations
9.
Liu, Fangfang, Gabriella Grisotti, Ronald R. Salem, et al.. (2018). Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma. Journal of Gastrointestinal Oncology. 9(3). 517–526. 3 indexed citations
10.
Guo, Xiaojia, Heino Velázquez, John Chang, et al.. (2016). Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism. Cancer Research. 76(13). 3884–3894. 45 indexed citations
11.
Guo, Xiaojia, Douglas MacPherson, Ling Wang, et al.. (2016). Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer. Scientific Reports. 6(1). 22996–22996. 35 indexed citations
12.
James, Edward, Xiangyu Cong, Xiaopan Yao, et al.. (2015). Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC).. Journal of Clinical Oncology. 33(3_suppl). 395–395. 11 indexed citations
13.
Stein, Stacey, Xiangyu Cong, Xiaopan Yao, et al.. (2015). Phase II study of Yale modified FOLFIRINOX (mFOLFIRINOX) in locally advanced pancreatic cancer (LAPC).. Journal of Clinical Oncology. 33(15_suppl). e15274–e15274. 1 indexed citations
14.
Fonseca, Annabelle L. & Charles Cha. (2014). Hepatocellular carcinoma: A comprehensive overview of surgical therapy. Journal of Surgical Oncology. 110(6). 712–719. 41 indexed citations
15.
Yoo, Peter S., Reynold I. Lopez‐Soler, Walter E. Longo, & Charles Cha. (2006). Liver Resection for Metastatic Colorectal Cancer in the Age of Neoadjuvant Chemotherapy and Bevacizumab. Clinical Colorectal Cancer. 6(3). 202–207. 106 indexed citations
16.
Cha, Charles, Ronald P. DeMatteo, & Leslie H. Blumgart. (2004). Surgical therapy for hepatocellular carcinoma.. PubMed. 38. 363–76. 6 indexed citations
17.
Cha, Charles, et al.. (2004). Long-term Results With Resection of Radiation-Induced Soft Tissue Sarcomas. Annals of Surgery. 239(6). 903–910. 133 indexed citations
18.
Cha, Charles, Herbert Chen, William H. Westra, & Robert Udelsman. (2002). Primary thyroid lymphoma: Can the diagnosis be made solely by fine-needle aspiration?. Annals of Surgical Oncology. 9(3). 298–302. 61 indexed citations
19.
Potters, Louis, Charles Cha, Richard Ashley, et al.. (2000). The role of external beam irradiation in patients undergoing prostate brachytherapy. Urologic Oncology Seminars and Original Investigations. 5(3). 112–117. 11 indexed citations
20.
Potters, Louis, et al.. (2000). Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.. PubMed. 5(5). 301–6. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026